rxstat › Shortages › Lorazepam

Lorazepam (Ativan) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Aug 27, 2026

A shortage of Lorazepam is anticipated but not yet confirmed. 3 product(s) have anticipated-shortage reports on file with Health Canada.

A benzodiazepine used for the short-term relief of anxiety.

Products affected
0 / 28
Reports on file
120

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
LORAZEPAM SUBLINGUAL
2MG · TABLET · AA PHARMA INC
DIN 02410761 · Disruption of the manufacture of the drug.
Anticipated
LORAZEPAM SUBLINGUAL
1MG · TABLET · AA PHARMA INC
DIN 02410753 · Disruption of the manufacture of the drug.
Anticipated
LORAZEPAM SUBLINGUAL
0.5MG · TABLET · AA PHARMA INC
DIN 02410745 · Disruption of the manufacture of the drug.
Resolved
LORAZEPAM SUBLINGUAL
1MG · TABLET · AA PHARMA INC
DIN 02410753 · ended Aug 21, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LORAZEPAM
0.5MG · TABLET · APOTEX INC
DIN 00655740 · ended Apr 30, 2026 · Disruption of the manufacture of the drug.
Resolved
LORAZEPAM INJECTION USP
4MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02243278 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LORAZEPAM
2MG · TABLET · TEVA CANADA LIMITED
DIN 00637750 · ended Mar 25, 2026 · Disruption of the manufacture of the drug.
Discontinued
ATIVAN
1MG · TABLET · PFIZER CANADA ULC
DIN 02041464
Discontinued
ATIVAN
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02041456
Resolved
TEVA-LORAZEPAM
2MG · TABLET · TEVA CANADA LIMITED
DIN 00637750 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LORAZEPAM
1MG · TABLET · TEVA CANADA LIMITED
DIN 00637742 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
Discontinued
ATIVAN
2MG · TABLET · PFIZER CANADA ULC
DIN 02041448

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Lorazepam to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Lorazepam is classified under “ANXIOLYTICS” (ATC N05BA).

Recent changes

Common questions

What is Lorazepam used for?

A benzodiazepine used for the short-term relief of anxiety.

When will Lorazepam be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Lorazepam in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (anxiolytics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Bromazepam (Lectopam) No current shortage Clobazam (Frisium) No current shortage Alprazolam (Xanax) Partial shortage 4 of 20 reported products affected Buspirone Partial shortage 2 of 8 reported products affected Diazepam (Diastat) Partial shortage 5 of 18 reported products affected · est. return Oct 23, 2026 Hydroxyzine (Atarax) Partial shortage 2 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.